Primary aldosteronism treatment response was associated with higher plasma renin activity and serum potassium levels and lower aldosterone.

When using high-flow nasal cannula (HFNC), setting a higher flow rate of 60 vs 40 L/min for post-extubation care did not improve key outcomes.

Edgewise Therapeutics , Inc. (NASDAQ:EWTX), with a market capitalization of $2.67 billion, is a biopharmaceutical company focused on developing innovative therapies for severe, rare muscle disorders.

The use of NMR technology is on the rise in the food industry, as this technology is helpful in a broad range of activities, ...

Almost three million were given ADHD drugs in the past two years, but for some they can cause more problems than they solve ...

Viking has long been viewed as a takeover target, given the positive data from early VK2735 trials. The company’s most recent update was in early November at Obesity Week, an ev ...

E3 Lithium” or the “Company,” a leader in Canadian lithium, is proud to announce its active participation in the ISO TC 333 Lithium mirror committee through the Standards Council of Canada (SCC). ISO ...

Further longer‐term and larger studies are required to make clearer recommendations regarding routine monitoring of pancreatic enzymes after initiation or dose up‐titration of tirzepatide… Outcomes of ...

Coulometric titrations offer a seamless transition path between classical and instrumental methods, offering several parallels between them, especially if visual indicators are used for determining ...

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some of its $215 million war chest to assess monthly dosing of the ...

In four of these cohorts, participants were given 0.6mg, 0.8mg, 1.0mg, or 1.2mg, weekly, without titration, for 12 weeks. Participants in the fifth cohort were also given weekly doses but this ...